Literature DB >> 19620524

Systematizing serendipity for cardiovascular drug discovery.

Peter J Schlueter1, Randall T Peterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19620524      PMCID： PMC2756982          DOI： 10.1161/CIRCULATIONAHA.108.824177

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  80 in total

Review 1.  Target-oriented and diversity-oriented organic synthesis in drug discovery.

Authors:  S L Schreiber
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 2.  Designing screens: how to make your hits a hit.

Authors:  W Patrick Walters; Mark Namchuk
Journal:  Nat Rev Drug Discov       Date:  2003-04       Impact factor: 84.694

Review 3.  Navigating chemical space for biology and medicine.

Authors:  Christopher Lipinski; Andrew Hopkins
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

4.  Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling.

Authors:  Charles C Hong; Quinn P Peterson; Ji-Young Hong; Randall T Peterson
Journal:  Curr Biol       Date:  2006-07-11       Impact factor: 10.834

5.  Identifying the proteins to which small-molecule probes and drugs bind in cells.

Authors:  Shao-En Ong; Monica Schenone; Adam A Margolin; Xiaoyu Li; Kathy Do; Mary K Doud; D R Mani; Letian Kuai; Xiang Wang; John L Wood; Nicola J Tolliday; Angela N Koehler; Lisa A Marcaurelle; Todd R Golub; Robert J Gould; Stuart L Schreiber; Steven A Carr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

6.  Comparative phosphoproteomics of zebrafish Fyn/Yes morpholino knockdown embryos.

Authors:  Simone Lemeer; Chris Jopling; Joost Gouw; Shabaz Mohammed; Albert J R Heck; Monique Slijper; Jeroen den Hertog
Journal:  Mol Cell Proteomics       Date:  2008-06-11       Impact factor: 5.911

7.  Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway.

Authors:  Albrecht Gruhler; Jesper V Olsen; Shabaz Mohammed; Peter Mortensen; Nils J Faergeman; Matthias Mann; Ole N Jensen
Journal:  Mol Cell Proteomics       Date:  2005-01-22       Impact factor: 5.911

8.  Genomic profiling of drug sensitivities via induced haploinsufficiency.

Authors:  G Giaever; D D Shoemaker; T W Jones; H Liang; E A Winzeler; A Astromoff; R W Davis
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

9.  The nongenotoxic carcinogens naphthalene and para-dichlorobenzene suppress apoptosis in Caenorhabditis elegans.

Authors:  David Kokel; Yehua Li; Jun Qin; Ding Xue
Journal:  Nat Chem Biol       Date:  2006-05-14       Impact factor: 15.040

10.  The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway.

Authors:  Yibing Qyang; Silvia Martin-Puig; Murali Chiravuri; Shuibing Chen; Huansheng Xu; Lei Bu; Xin Jiang; Lizhu Lin; Anne Granger; Alessandra Moretti; Leslie Caron; Xu Wu; Jonathan Clarke; Makoto M Taketo; Karl-Ludwig Laugwitz; Randall T Moon; Peter Gruber; Sylvia M Evans; Sheng Ding; Kenneth R Chien
Journal:  Cell Stem Cell       Date:  2007-06-14       Impact factor: 24.633
View more
  7 in total

1.  Drug discovery in a multidimensional world: systems, patterns, and networks.

Authors:  Joel T Dudley; Eric Schadt; Marina Sirota; Atul J Butte; Euan Ashley
Journal:  J Cardiovasc Transl Res       Date:  2010-07-31       Impact factor: 4.132

2.  Traversing the valley of death: a guide to assessing prospects for translational success.

Authors:  Barry S Coller; Robert M Califf
Journal:  Sci Transl Med       Date:  2009-12-09       Impact factor: 17.956

3.  In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling.

Authors:  Jason R Becker; Tamara Y Robinson; Chetana Sachidanandan; Amy E Kelly; Shannon Coy; Randall T Peterson; Calum A MacRae
Journal:  Cardiovasc Res       Date:  2011-12-23       Impact factor: 10.787

Review 4.  Targeting the undruggable proteome: the small molecules of my dreams.

Authors:  Craig M Crews
Journal:  Chem Biol       Date:  2010-06-25

5.  In vivo chemical screening for modulators of hematopoiesis and hematological diseases.

Authors:  Yiyun Zhang; J-R Joanna Yeh
Journal:  Adv Hematol       Date:  2012-06-19

6.  BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database.

Authors:  Chifeng Ma; Hung-I Chen; Mario Flores; Yufei Huang; Yidong Chen
Journal:  BMC Syst Biol       Date:  2013-12-09

7.  Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates.

Authors:  Zongliang Chang; Weibing Qin; Huili Zheng; Kathleen Schegg; Lu Han; Xiaohua Liu; Yue Wang; Zhuqing Wang; Hayden McSwiggin; Hongying Peng; Shuiqiao Yuan; Jiabao Wu; Yongxia Wang; Shenghui Zhu; Yanjia Jiang; Hua Nie; Yuan Tang; Yu Zhou; Michael J M Hitchcock; Yunge Tang; Wei Yan
Journal:  Nat Commun       Date:  2021-02-23       Impact factor: 14.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.